Belotendos, Baby Girl -.

HRN: 29-32-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMPICILLIN 250MG (VIAL)
07/17/2026
07/23/2026
IV
150mg
Q12
PSNB
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: